Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Familial hypercholesterolaemia: identification and management

Clinical guideline
Reference number: CG71
Published: 27 August 2008
Last updated: 04 October 2019

History

Expected publication

Committee member list (PDF 379 KB)

Published:

02 November 2017
Consultation comments and responses (PDF 1.13 MB)

Published:

02 November 2017
Equality impact assessment (PDF 364 KB)

Published:

29 November 2017

Addendum consultation

Addendum consultation
Comments form (MSWord 63 KB)

Published:

12 May 2017
Equality impact assessment - Section 3 (PDF 262 KB)

Published:

12 May 2017
Committee member list and declarations of interests (PDF 333 KB)

Published:

12 May 2017
Key research recommendations (MSWord 27 KB)

Published:

12 May 2017
Addendum (PDF 7.35 MB)

Published:

12 May 2017
Short version of addendum (PDF 705 KB)

Published:

12 May 2017

Stakeholder list updated

Stakeholder list (PDF 269 KB)

Published:

10 May 2017

Review questions document published

Review questions (PDF 266 KB)

Published:

01 December 2016

Committee list updated

Committee member list (PDF 115 KB)

Published:

01 December 2016

Committee meetings

Committee meeting
Minutes (PDF 310 KB)

Published:

29 March 2017
Minutes (PDF 313 KB)

Published:

29 March 2017
Committee meeting
Minutes (PDF 284 KB)

Published:

02 November 2017

Pre-consultation documents released

Committee member list (PDF 55 KB)

Published:

12 May 2016
Review questions (PDF 182 KB)

Published:

12 May 2016

List of registered stakeholders

List of registered stakeholders (PDF 44 KB)

Published:

01 September 2015

Original development on 01 August 2008

Review documents
CG71 Familial hypercholesterolaemia: review proposal consultation information
CG71 Familial hypercholesterolaemia: review proposal (PDF 282 KB)

Published:

27 June 2011
Familial hypercholesterolaemia: review decision (PDF 153 KB)

Published:

11 August 2011
Familial hypercholesterolaemia: draft consultation comments
Familial hypercholesterolaemia: draft consultation comments
Familial hypercholesterolaemia: draft consultation comments 1 (PDF 255 KB)

Published:

27 August 2008
Familial hypercholesterolaemia: draft consultation comments 2 (PDF 264 KB)

Published:

27 August 2008
Familial hypercholesterolaemia: draft scope
Familial hypercholesterolaemia: draft scope (PDF 112 KB)

Published:

15 July 2008
Familial hypercholesterolaemia: GDG minutes
Familial hypercholesterolaemia: GDG minutes
Familial hypercholesterolaemia: GDG minutes 23 June 2008 (PDF 70 KB)

Published:

12 August 2008
Familial hypercholesterolaemia: GDG minutes 2 May 2008 (PDF 76 KB)

Published:

10 July 2008
Familial hypercholesterolaemia: GDG minutes 11 January 2008 (PDF 78 KB)

Published:

10 July 2008
Familial hypercholesterolaemia: consultation
Familial hypercholesterolaemia: consultation information
Familial hypercholesterolaemia: Full guideline (PDF 1.43 MB)

Published:

08 February 2008
Familial hypercholesterolaemia: NICE guideline (PDF 701 KB)

Published:

08 February 2008
Familial hypercholesterolaemia: Appendix A (PDF 113 KB)

Published:

08 February 2008
Familial hypercholesterolaemia: Appendix B (PDF 212 KB)

Published:

08 February 2008
Familial hypercholesterolaemia: Appendix C (PDF 1.43 MB)

Published:

08 February 2008
Familial hypercholesterolaemia: Appendix D (PDF 47 KB)

Published:

08 February 2008
Familial hypercholesterolaemia: Appendix E (PDF 343 KB)

Published:

08 February 2008
Familial hypercholesterolaemia: Appendix F (PDF 73 KB)

Published:

08 February 2008
Familial hypercholesterolaemia: Appendix G (PDF 53 KB)

Published:

08 February 2008
Familial hypercholesterolaemia: Comments proforma (MSWord 41 KB)

Published:

08 February 2008
Appendix A (PDF 113 KB)

Published:

06 December 2013
Familial hypercholesterolaemia: comments on draft scope
Familial hypercholesterolaemia: draft scope (PDF 112 KB)

Published:

15 July 2008
Familial hypercholesterolaemia: final scope
Familial hypercholesterolaemia: final scope (PDF 115 KB)

Published:

08 February 2007
Familial hypercholesterolaemia: GDG membership
Familial hypercholesterolaemia: GDG membership (PDF 26 KB)

Published:

01 February 2007
Familial Hypercholesterolaemia: Draft Scope, comments form
Familial Hypercholesterolaemia: Draft Scope, comments form (MSWord 47 KB)

Published:

10 July 2006
Familial hypercholesterolaemia: remit
Familial hypercholesterolaemia: remit information
National Collaborating Centre for Primary Care
National Collaborating Centre for Primary Care information
The guideline development process - an overview for stakeholders, the public and the NHS (third edition)
The guideline development process - an overview for stakeholders, the public and the NHS (third edition) information
The guideline development process - an overview for stakeholders, the public and the NHS (third edition) (PDF 174 KB)

Published:

25 April 2007
The guideline development process - an overview for stakeholders, the public and the NHS
The guideline development process - an overview for stakeholders, the public and the NHS information